CD163 (CD163)

CD163 is an acute phase-regulated receptor involved in clearance and endocytosis of hemoglobin/haptoglobin complexes by macrophages and may thereby protect tissues from free hemoglobin-mediated oxidative damage.

Swiss-Prot Accession Number: Q86VB7


 
Therapy Indications
Autoimmune Disease and Arthritis
Cancer
Cardiac and Vascular Markers/Disease
Inflammation and Immune Response
 
Myriad RBM Publications Publications
Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE (2018) Casey KA, Guo X, Smith MA, Wang S, Sinibaldi D, Sanjuan MA, Wang L, Illei GG, White WI Lupus Science and Medicine
Speak to a Scientist